Abstract
Though oseltamivir and zanamivir are the active anti-influenza drugs, the emergence of different strains of influenza A virus with mutations creates drug-resistance to these drugs. Therefore, it is essential to find a suitable approach to stop the viral infection. The present study focuses on understanding the conformational changes of the HA2 protein at different pH levels (pH 7, pH 6, pH 5) and on blocking the low pH-induced conformational changes of the HA2 protein with a suitable ligand using molecular docking and molecular dynamics (MD) simulation methods. As the pH value decreases to pH 5, the protein undergoes large conformational changes with less stability in the order of pH 7 > pH 6 > pH 5. The fusion peptide (residues 1–20) and the extended loop (residues 58–75) deviate more at pH 5. The ligand stachyflin bound between the N- and C-terminal helix regions retains the stability of the HA2 protein at pH 5 and blocks the low pH-induced conformational transition. The performance of stachyflin is increased when it directly interacts with residues at the intramonomer binding site rather than the intermonomer binding site. The susceptibility of the HA2 protein of different subtypes to stachyflin is in the order of H1 > H7 > H5 > H2 > H3. Stachflin has a higher binding affinity for H1 (at pH 7, pH 6, pH 5) and H7 subtypes than others. Lys47, Lys58, and Glu103 are the key residues that favor the binding and highly stabilize the HA2 protein at low pH.
Similar content being viewed by others
References
Flahault A, Zylberman P (2010) Influenza pandemics: past, present and future challenges. Public Health Rev 32:319–340
World Health Organization Global Influenza Program Surveillance Network (2005) Evolution of H5N1 avian influenza viruses in Asia. Emerging Infect Dis 11:1515–1521
Fineberg HV (2014) Pandemic preparedness and response lessons from the H1N1 influenza of 2009. N Engl J Med 370:1335–1342
Cheng QL, Ding H, Sun Z, Kao QJ, Yang XH, Huang RJ, Wen YY, Wang J, Xie L (2015) Retrospective study of risk factors of mortality in human avian influenza a (H7N9) case in Zhejiang Province, China. Int J Infect Dis 13:S1201–S9712
Kannan S, Kolandaivel P (2016) Computational studies of pandemic 1918 and 2009 H1N1 hemagglutinins bound to avian and human receptor analogs. J Biomol Struct Dyn 34:272–289
Eefie JAS, Ron AMF (2014) Host adaptation and transmission of influenza a viruses in mammals. Emerging Microbes Infect 3:1–10
Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, Chen LM, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Gilbert AT, Chang J, Guo Z, Davs CT, Paulson JC, Stevens J, Rupprecht CE, Holmes EC, Wilson IA, Donis RO (2013) New World Bats Harbor diverse influenza a viruses. PLoS Pathog 9:e1003657
Kannan S, Kolandaivel P (2017) Antiviral potential of natural compounds against influenza virus hemagglutinin. Comput Biol Chem 71:207–218
Ohuchi M, Ohuchi R, Sakai T, Matsumoto A (2002) Tight binding of influenza virus hemagglutinin to its receptor interfaces with fusion pore dilation. J Virol 76:12405–12413
Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P (2013) Influenza a penetrates host mucus by cleaving sialic acids with neuraminidse. J Virol 10:321
Pinto LH, Lamb RA (2006) The M2 proton channels of influenza a and B viruses. J Biol Chem 281:8997–9000
Ison MG (2011) Antivirals and resistance: influenza virus. Curr Opin Virol 1:563–573
Deyde VM, Xu XY, Bright RA, Shaw M, Smith CB, Zhang Y, Shu YL, Gubareva LV, Cox NJ, Klimov AI (2007) Surveillance of resistance to adamantanes among influenza a(H3N2) and a(H1N1) viruses isolated worldwide. J Infect Dis 196:249–257
Memoli M, Hrabal R, Hassantoufighi A, Eichelberger M, Taubenberger J (2010) Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis 50:1252–1255
Kannan S, Kolandaivel P (2017) The inhibitory performance of flavonoid cyaniding-3-sambubiocide against H274Y mutation in H1N1 influenza virus. J Biomol Struct Dyn 20:1–15
Reed ML, Bridges OA, Seiler P, Kim JK, Yen HL, Salomon R, Govorkova EA, Webster RG, Russell CJ (2010) The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84:1527–1535
Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza hemagglutinin at the pH of memebrane fusion. Nature 371:37–43
Skehel JJ, Wiley DC (2000) Receptor binding and memebrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569
Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, Kuntz ID (1993) Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32:2967–2978
Russel RJ, Kerry PS, Stevns DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ (2008) Structure of influenza hemagglutinin in complex with an inhibitor of memebrane fusion. Proc Natl Acid Sci USA 105:17736–17741
Boriskin YS, Lenev IA, Pecheur EI, Polyak SJ (2008) Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem 15:997–1005
Plotch SJ, O’Hara B, Morin J, Palant O, LaRocque J, Bloom JD, Lang SAJ, DiGrandi MJ, Bradley M, Nilakantan R, Gluzman Y (1999) Inhibition of influenza a virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin. J Virol 73:140–151
Zhu Z, Li R, Xiao G, Chen Z, Yang J, Zhu Q, Liu S (2012) Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion. Eur J Med Chem 57C:211–216
Yoshimoto J, Kakui M, Iwasaki H, Fujiwara T, Sugimoto H, Hattori N (1999) Identification of a novel HA conformational change inhibitor of human influenza virus. Arch Virol 144:865–878
Minagawa K, Kouzuki S, Kamigauchi T (2002) Stachyflin and acetylstachyflin, novel anti-influenza a virus substances, produced by Stachybotrys sp. RF-7260. II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives. J Antibiot 55:165–171
Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA (1998) Inhibition of influenza virus hemagglutinin –mediated memebrane fusion by a compound related to podocarpic acid. Virology 248:246–274
Luo G, Colonno R, Krystal M (1996) Characterization of a hemagglutinin-specific inhibitor of influenza a virus. Virology 226:66–76
Hoffman LR, Kuntz ID, White JM (1997) Structure-based identification of an induce of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J Virol 71:8808–8820
Xu R, Ekiert DC, Krause JC, Hai R, Crowe Jr JE, Wilson IA (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357–360
Xu R, McBride R, Paulson JC, Basler CF, Wilson IA (2010) Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J Virol 84:1715–1721
Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, Lee JH, Dillon MA, O’Neil RE, Faynboym AM, Horowitz M, Horowitz L, Ward AB, Palese P, Webby R, Lerner RA, Bhatt RR, Wilson IA (2012) Cross-neutralization of influenza a viruses mediated by a single antibody loop. Nature 489:526–532
Yamada S, Suzuki Y, Suzuki T, Le MQ, Ca N, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y (2006) Hemagglutinin mutations responsible for the binding of H5N1 influenza a viruses to human-type receptors. Nature 444:378–382
Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, McCauley JW, Collins PJ, Walker PA, Skehel JJ, Gamblin SJ (2013) Receptor binding by an H7N9 influenza virus from humans. Nature 499:496–499
Bernstein FC, Koetzle TF, Williams GJ, Meyer EFJ, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M (1977) The protein data Bank: a computer-based archival file for macromolecular structures. Eur J Biochem 80:319–324
Wlodawer A, Minor W, Dauter Z, Jaskolski M (2008) Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 275:1–21
Gordon JC, Myers JB, Folta T, Shoja V, Heath LS, Onufriev A (2005) H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleiv Acids Res 33:W368–W371
Pahari S, Sun L, Basu S, Alexov E (2018) DelPhiPKa: including salt in the calculations and enabling polar residues to titrate. Proteins 86:1277–1283
Hohenstein EG, Chill ST, Sherrill CD (2008) Assessment of the performance of the M05-2X and M06-2X exchange-correlation functional for noncovalent interactions in biomolecules. J Chem Theory Comput 4:1996–2000
Gu J, Wang J, Leszczynski J (2011) Stacking and H-bonding patterns of dGpdC and dGpdCpdG: performance of the M05-2X and M06-2X Minnesota density functional for the single strand DNA. Chem Phys Lett 512:108–112
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Chessman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JAJ, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavchari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian Inc., Wallingford
Thompson MA (2004) ArgusLab 4.0.1. Planaria software LLC., Seattle. http://www.ArgusLab.com
Thompson MA (2004) Poster presentation: molecular docking using arguslab: an efficient shape-based search algorithm & the AScore scoring function. Fall ACS meeting, Philadelphia
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31:455–461
Oda A, Okayasu M, Kamiyama Y, Yoshida T, Takahashi O, Matsuzaki H (2007) Evaluation of docking accuracy and investigation of roles of parameters and each term in scoring function for protein-ligand using ArgusLab software. B Chem Soc Jpn 80:1920–1925
Erickson JA, Jalaie M, Robertson DH, Lewis RA, Vieth M (2004) Lessons in molecular recognition: the effects of ligands and protein flexibility on molecular docking accuracy. J Med Chem 47:45–55
Castro-Alvarez A, Costa AM, Vilarrasa J (2017) The performance of several docking programs at reproducing protein-macrolide-like crystal structures. Molecules 22:1–14
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177–6196
Van Der SD, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) GROMACS: fast, flexible and free. J Comput Chem 26:1701–1718
Berendsen HJC, Postma JPM, Gunsteren WFV, Hermans J (1981) Interaction models for water in relation to protein hydration. Intermolecular Forces 14:331–342
Schuttelkopf AW, Van Aalten DM (2004) PRODRG-a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr section D Biol Crystallogr 60:1355–1363
Parrinello M (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182
Kumari R, Kumar R, Open Source Drug Discovery Consortium, Lynn A (2014) g_mmpbsa a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951–1962
Song D, Xu H, Liu S (2013) Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligands. J Mol Model 19:5561–5568
Li R, Song D, Zhu Z, Xu H, Liu S (2012) An induced pocket for the binding of potent fusion inhibitors CL-385319 with H5N1 influenza virus hemagglutinin. PLoS One 7:e41956
Yanagita H, Yamamoto N, Fuji H, Liu X, Ogata M, Yokota M, Takaku H, Hasegawa H, Odagiri T, Tashiro M, Hoshino T (2012) Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function. ACS Chem Biol 7:552–562
Lin X, Noel JK, Wang Q, Ma J, Onuchic JN (2016) Lowered pH leads to fusion peptide release and a highly dynamic intermediate of influenza hemagglutinin. J Phys Chem B 120:9654–9660
Basu S, Mukharjee D (2017) Salt-bridge network within globular and disordered proteins: characterizing trends for designable interactions. J Mol Model 23:206
Yoshimoto J, Kakui M, Iwasaki H, Sugimoto H, Fujiwara T, Hattori N (2000) Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin. Microbiol Immunol 44:677–685
Motohashi Y, Igarashi M, Okamatsu M, Noshi T, Sakoda Y, Yamanoto N, Ito K, Yoshida R, Kida H (2013) Antiviral activity of stachyflin on influenza a viruses of different hemagglutinin subtypes. Virol J 10:118
Acknowledgments
S. Kannan expresses his sincere thanks to CSIR, Govt. Of. India, New Delhi for the award of Senior Research Fellowship (Grant No: 09/472(0177)/2016- EMR-1 dated: 31.03.2017). Prof. P. Kolandaivel is thankful to UGC for the award of UGC BSR faculty fellowship.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 2402 kb)
Rights and permissions
About this article
Cite this article
Kannan, S., Shankar, R. & Kolandaivel, P. Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach. J Mol Model 25, 99 (2019). https://doi.org/10.1007/s00894-019-3982-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00894-019-3982-y